AberTea: fermented seaweed English breakfast tea for heart and blood vessel health during menopause
Official title: The Effect of the Fermented Seaweed Enriched Abertay Tea on Vascular Function and Markers of Cardiovascular Risk During Menopause
Run by Abertay University · NCT07070635 · Data updated 2026-11-12
This trial will test whether drinking three cups a day of AberTea (English breakfast tea enriched with fermented brown seaweed) for eight weeks can improve blood pressure and blood vessel function in postmenopausal women.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 74 Years |
| Sex | Women only |
| Enrollment | 44 (estimated) |
| Sponsor | Abertay University Academic / other |
| Locations | 1 site (Dundee) |
| Status | Recruiting |
| Started | June 16, 2025 |
| Main results expected | October 2025 |
| Study ends | November 2025 |
| Registry record updated | July 17, 2025 |
| Trial ID | NCT07070635 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are postmenopausal women who regularly drink tea, have a BMI of 18.5–39.99 kg/m2, and do not have major cardiovascular disease, diabetes, or contraindicating medications.
✕Probably not a fit
Women with existing cardiovascular disease, diabetes, recent cancer, thyroid impairment, active smokers or vapers, excessive alcohol intake, recent hormone therapy, or on excluded medications are not eligible and unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Abertay University will run a double-blind, parallel randomized trial comparing AberTea — an English breakfast tea enriched with fermented brown seaweed — to a control English breakfast tea over eight weeks. Postmenopausal women who are regular tea drinkers will be randomly assigned to drink three cups daily and will undergo fasting baseline and endpoint visits for blood pressure, vascular function testing, and blood sampling. Primary outcomes are blood pressure and vascular function, with secondary outcomes including lipoprotein profiles and glycaemic control; participants are asked not to change diet or activity. Recruitment will occur via university emails, posters, social media and local outreach, with screening to confirm eligibility and safety.
Why it matters
Potential benefit: If successful, the tea could modestly lower blood pressure and improve vascular health in postmenopausal women through a simple daily beverage.
How similar studies have gone: Previous interventional studies of brown seaweed or its extracts have shown reductions in blood pressure and improvements in lipids and glycaemic markers in some populations, though effects vary by seaweed type, dose, and duration.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Postmenopausal status: no menstrual period over the last 12 months * Regular tea drinkers (at least once a week), willingness to consume 3 cups of English breakfast tea per day for 8 weeks * BMI between 18.5 and 39.99 kg/m2 Exclusion Criteria: * Reported history of CVD (myocardial infarction, angina, venous thrombosis, stroke, dyslipidemia), diabetes (or fasting glucose ≥ 6.1 mmol/L), kidney, liver or bowel disease. * Recent history of cancer (\<1y) * History indicative of a congenital or acquired platelet or haemostatic defect. * Presence of gastrointestinal disorder or use of drug, which is likely to alter gastrointestinal motility or nutrient absorption. * Recent use of hypolipidaemic, antiplatelet or antithrombotic medications * Impairment of thyroid function * Current smokers or vapers * Current self-reported weekly alcohol intake exceeding 14 units * Current or recent use of hormone replacement therapy (\<3 months) * Recent participation in another clinical trial (\<3 months) * Allergy or intolerance to crustaceans or iodine
Where it's running
-
Abertay University
Dundee, United Kingdom Recruiting
Study contacts
- Principal investigator: Sarah C Cottin, PhD — Abertay University
- Study coordinator: Sarah C Cottin, PhD
- Email: s.cottin@abertay.ac.uk
- Phone: +44(0)1382308780
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if stopping alcohol can lower blood pressure and heart risk in adults who drink and have hypertension
This study tests whether abstaining from alcohol for 8 weeks can improve blood pressure and heart-health markers in adults who regularly drink and have high blood pressure.
-
Equol and vascular function in women with CKD
This study tests whether taking equol for 12 weeks improves vascular function in postmenopausal women with chronic kidney disease.
-
Adding nitrate to everyday oat-based foods to boost nitric oxide and support blood vessel health.
We will test whether adding inorganic nitrate to oat-based foods boosts nitric oxide levels and lowers blood pressure in healthy adults aged 18–60.
-
Adding fostemsavir to reduce inflammation in people with well-controlled HIV
This trial will test whether adding fostemsavir to current HIV treatment lowers inflammation and heart disease risk for people with well-controlled HIV who have detectable sgp120.
-
Preventive screening and health coaching for people facing food insecurity
A health coaching program delivered virtually is being tested to see if it lowers heart-disease risk and improves blood pressure, cholesterol, and diabetes markers in low-income adults who have limited access to food and healthcare.
-
Improving vascular health in patients with hypertension through medication and exercise
This study is testing whether a combination of blood pressure medication and personalized exercise can help people with high blood pressure improve their heart and blood vessel health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.